Concepedia

Lori Schmid

LS

Statistics

Publications

4

Citations

388

H-Index

4

Active since

2003

Affiliations

Purdue Pharma (Canada)(Current)

Purdue Pharma (United States)

Lori Schmid is an author at Purdue Pharma (Canada) specializing in pharmacotherapy, drug discovery, and medicine.

Top concepts

Publications per year

2003–2004

4

Publications

4

N-(4-Tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2 H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: I. In Vitro Characterization and Pharmacokinetic Properties

Kenneth J. Valenzano, Elfrida R. Grant, Gang Wu et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 249 citations · Full text

4-(2-Pyridyl)piperazine-1-carboxamides: potent vanilloid receptor 1 antagonists

Qun Sun, Laykea Tafesse, Khondaker Islam et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 49 citations · Full text

, , +4

4-(2-Pyridyl)piperazine-1-benzimidazoles as potent TRPV1 antagonists

Bin Shao, Jincheng Huang, Qun Sun et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 47 citations · Full text

, , +5

Synthesis and evaluation of pyridazinylpiperazines as vanilloid receptor 1 antagonists

Laykea Tafesse, Qun Sun, Lori Schmid et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 43 citations · Full text

, , +8

1–4 of 4